Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update Post published:November 15, 2021 Post category:Press Release
Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder Post published:November 15, 2021 Post category:Press Release
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory Post published:November 15, 2021 Post category:Press Release
PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch Post published:November 11, 2021 Post category:Press Release
Silo Pharma Reports Third Quarter Results and Operating Highlights Post published:November 11, 2021 Post category:Press Release
Mydecine’s Chief Medical Officer, Dr. Rakesh Jetly, to Participate at Horizons’ Veterans & Families Forum on November 10, 2021 Post published:November 10, 2021 Post category:Press Release
Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials Post published:November 10, 2021 Post category:Press Release
Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study Post published:November 10, 2021 Post category:Press Release
Nova Mentis Files Genetic Neuroinflammatory Disease Patent Post published:November 9, 2021 Post category:Press Release
MYND Executes LOI to Enter into a Clinical Research Collaboration with Revitalist Post published:November 9, 2021 Post category:Press Release